These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2611096)

  • 1. Omeprazole.
    Gazzard BG
    Br J Clin Pract; 1989 Nov; 43(11):408-11. PubMed ID: 2611096
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; gastric mucosa proton pump inhibitors].
    Okabe S; Akimoto Y
    Nihon Rinsho; 1988 Jan; 46(1):33-8. PubMed ID: 2836641
    [No Abstract]   [Full Text] [Related]  

  • 3. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole and acid inhibition: the essential issues. Proceedings of a symposium. London, April 1990.
    Digestion; 1990; 47 Suppl 1():1-84. PubMed ID: 1982661
    [No Abstract]   [Full Text] [Related]  

  • 5. [New special drugs registered in Austria. Losec (omeprazole)].
    Farr C; Georgieff GS
    Wien Klin Wochenschr; 1991; 103(11):343-8. PubMed ID: 1858386
    [No Abstract]   [Full Text] [Related]  

  • 6. [New pharmacologic perspectives in the therapy with antisecretory agents: omeprazole].
    Esplugues JV; García AG
    Rev Clin Esp; 1991 Apr; 188(6):301-5. PubMed ID: 1780532
    [No Abstract]   [Full Text] [Related]  

  • 7. Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
    Topaloglu U; Muftuoglu T; Akturk Z; Ekinci H; Peker O; Unalmiser S
    Surg Today; 2004; 34(8):690-4. PubMed ID: 15290400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A turnover model of irreversible inhibition of gastric acid secretion by omeprazole in the dog.
    Abelö A; Eriksson UG; Karlsson MO; Larsson H; Gabrielsson J
    J Pharmacol Exp Ther; 2000 Nov; 295(2):662-9. PubMed ID: 11046103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of gastric acidity in horses.
    Murray MJ
    J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
    Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
    Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of rat gastric mucosal response to potent acid inhibition.
    Nørsett KG; Laegreid A; Langaas M; Wörlund S; Fossmark R; Waldum HL; Sandvik AK
    Physiol Genomics; 2005 Jun; 22(1):24-32. PubMed ID: 15827235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
    Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric mucosal function following withdrawal of omeprazole in rats.
    Noto T; Nagasaki M; Yomota E; Endo T
    Arzneimittelforschung; 1998 Jan; 48(1):70-3. PubMed ID: 9522036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
    Konturek SJ; Cieszkowski M; Kwiecień N; Konturek J; Tasler J; Bilski J
    Gastroenterology; 1984 Jan; 86(1):71-7. PubMed ID: 6689674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of inducible heat shock protein 70 in the gastric mucosa of partially sleep-deprived rats.
    Guo JS; Chau JF; Shen XZ; Cho CH; Luk JM; Koo MW
    Scand J Gastroenterol; 2004 Jun; 39(6):510-5. PubMed ID: 15223672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer.
    Howden CW; Derodra JK; Burget DW; Hunt RH
    Hepatogastroenterology; 1986 Dec; 33(6):267-70. PubMed ID: 3804185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.